|
Plasmids. mRNA. Oligos. Cell and gene therapies. Antibody variants. Vaccines. We all know these advanced therapies hold huge potential. But developing them isn’t straightforward, and failing too late can be costly. At Cytiva, we’ve spent decades helping scientists turn vision into reality. |